BioNexus Gene Lab(us:BGLC)

    0.2349

    +2.62%

    Updated on 2024-12-23

    Open:0.2379
    Close:0.2349
    High:0.2520
    Low:0.2140
    Pre Close:0.2289
    Volume:326456.00
    Amount:76206.42
    Turnover:1.82%
    Shares:17.97M
    MarketCap:4.22M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-304657250.37%003
    2024-03-3171010390.57%213
    2023-12-3161041710.59%104
    2023-09-3052035811.14%500
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Virtu Financial Llc470370.27%2088879.88%
    2024-03-31Geode Capital Management, Llc236810.13%0
    2024-03-31Hrt Financial Lp219030.12%21903
    2024-03-31Ubs Group Ag84180.05%8418
    2024-03-31Two Sigma Securities, Llc0-14919
    2024-03-31Citadel Advisors Llc0-33591
    2024-03-31Tower Research Capital Llc (Trc)0-5831
    2023-12-31Citadel Advisors Llc335910.19%-18160-35.09%
    2023-12-31Virtu Financial Llc261490.15%-33539-56.19%
    2023-12-31Geode Capital Management, Llc236810.13%0

    About

    BioNexus Gene Lab Corp. operates as a holding company, which engages in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries. It is also involved in the development of liquid biopsy tests for the early detection of biomarkers that are linked to diseases. It operates through the BioNexus Malaysia and Chemrex segments. The company was founded on May 12, 2017 and is headquartered in Kuala Lumpur, Malaysia.
    Address:Tower B, Vertical Business Suite,Bangsar South, 8 Jalan Kerinchi,Unit 02, Level 10

    Market Movers